![Arti Ahluwalia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arti Ahluwalia
Nessuna posizione attualmente
Profilo
Arti Ahluwalia was the founder of Kirkstall Ltd.
which was founded in 2000, where she held the title of Research Director from 2000 to 2013.
Ms. Ahluwalia's former jobs include being an Associate Professor at the University of Pisa and a Principal at Tissue Engineering Technologies AG.
Precedenti posizioni note di Arti Ahluwalia
Società | Posizione | Fine |
---|---|---|
University of Pisa | Corporate Officer/Principal | - |
Tissue Engineering Technologies AG
![]() Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Corporate Officer/Principal | - |
Kirkstall Ltd.
![]() Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Kirkstall Ltd.
![]() Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Health Technology |
Tissue Engineering Technologies AG
![]() Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Health Technology |
- Borsa valori
- Insiders
- Arti Ahluwalia